Stock Events

Stock Events

Cochlear 

€46.60
135
+€0.00+0%Thursday 07:22

Statistics

Day High
46.6
Day Low
46.6
52W High
81
52W Low
29.2
Volume
0
Avg. Volume
0
Mkt Cap
3.05B
P/E Ratio
-
Dividend Yield
2.26%
Dividend
1.05

Upcoming

Dividends

2.26%Dividend Yield
Nov 2026
€0.40
Apr 2026
€0.65
Oct 2025
€0.59
Apr 2025
€0.60
Oct 2024
€0.65
10Y Growth
2.91%
5Y Growth
5.14%
3Y Growth
1.41%
1Y Growth
-11.61%

Earnings

Aug 17Expected
Q4 2025
Q2 2026
1.01
1.26
1.52
1.77
Expected EPS
1.007533740245131
Actual EPS
1.1645834986499999

Financials

6.05%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.38BRevenue
83.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OC50.MU. It's not an investment recommendation.
Commonwealth Bank of Australia
40
CBA.AU
CSL
40
CSL.AU
BHP Group Limited
34
BHP.AU
Fortescue
29
FMG.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AllianceBernstein Lp
AB
Mkt Cap3.22B
Advanced Bionics is a direct competitor in the cochlear implant space, offering similar hearing solutions.
Sonos
SONO
Mkt Cap1.91B
Sonova Holding AG is a leading provider of hearing care solutions, competing across several product lines including cochlear implants.
Demant AS
WILYY
Mkt Cap8.71B
William Demant Holding operates in the hearing aids and audiological equipment market, indirectly competing with Cochlear.
Solana
HSDT
Mkt Cap136.07M
Helius Medical Technologies focuses on neurological wellness, which could indirectly compete with Cochlear by offering alternative treatments for conditions affecting hearing.

About

Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Show More
CEO
Diggory William Howitt
Employees
5400
Country
Australia
ISIN
US1914592050
WKN
000A1C3B8

Listings

MX
MX
COHN.MX
STU
DE
OC5.STU
MU
DE
OC5.MU
OTC Link
US
CHEOY

0 Comments

Share your thoughts

FAQs

What is Cochlear stock price today?▼
The current price of OC50.MU is €46.60 EUR — it has increased by +0% in the past 24 hours. Watch Cochlear stock price performance more closely on the chart.
What is Cochlear stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Cochlear stocks are traded under the ticker OC50.MU.
Is Cochlear stock price growing?▼
OC50.MU stock has risen by +5.43% compared to the previous week, the month change is a +15.92% rise, over the last year Cochlear has showed a -42.47% decrease.
What is Cochlear market cap?▼
Today Cochlear has the market capitalization of 3.05B
When is the next Cochlear earnings date?▼
Cochlear is going to release the next earnings report on February 16, 2027.
What were Cochlear earnings last quarter?▼
OC50.MU earnings for the last quarter are 1.16 EUR per share, whereas the estimation was 1.01 EUR resulting in a +15.59% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Cochlear revenue for the last year?▼
Cochlear revenue for the last year amounts to 1.38B EUR.
What is Cochlear net income for the last year?▼
OC50.MU net income for the last year is 83.21M EUR.
Does Cochlear pay dividends?▼
Yes, OC50.MU dividends are paid semi-annual. The last dividend per share was 0.4 . As of today, Dividend Yield (FWD)% is 2.26%.
How many employees does Cochlear have?▼
As of November 7, 2026, the company has 5,400 employees.
In which sector is Cochlear located?▼
Cochlear operates in the Health & Wellness sector.
When did Cochlear complete a stock split?▼
Cochlear has not had any recent stock splits.
Where is Cochlear headquartered?▼
Cochlear is headquartered in Sydney, Australia.